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Abstract
Background: Status epilepticus (SE) is proposed to lead to an age-dependent acute activation of a repertoire of
inflammatory processes, which may contribute to neuronal damage in the hippocampus. The extent and temporal
profiles of activation of these processes are well known in the adult brain, but less so in the developing brain. We
have now further elucidated to what extent inflammation is activated by SE by investigating the acute expression
of several cytokines and subacute glial reactivity in the postnatal rat hippocampus.
Methods: SE was induced by an intraperitoneal (i.p.) injection of kainic acid (KA) in 9- and 21-day-old (P9 and P21)
rats. The mRNA expression of interleukin-1 beta (IL-1b), tumor necrosis factor-alpha (TNF-a), interleukin-10 (IL-10),
matrix metalloproteinase-9 (MMP-9), glial-derived neurotrophic factor (GDNF), interferon gamma (IFN-g), and
transforming growth factor-beta 1 (TGF-b1) were measured from 4 h up to 3 days after KA injection with real-time
quantitative PCR (qPCR). IL-1b protein expression was studied with ELISA, GFAP expression with western blotting,
and microglial and astrocyte morphology with immunohistochemistry 3 days after SE.
Results: SE increased mRNA expression of IL-1b, TNF-a and IL-10 mRNA in hippocampus of both P9 and P21 rats,
their induction being more rapid and pronounced in P21 than in P9 rats. MMP-9 expression was augmented
similarly in both age groups and GDNF expression augmented only in P21 rats, whereas neither IFN-g nor TGF-b1
expression was induced in either age group. Microglia and astrocytes exhibited activated morphology in the
hippocampus of P21 rats, but not in P9 rats 3 d after SE. Microglial activation was most pronounced in the CA1
region and also detected in the basomedial amygdala.
Conclusion: Our results suggest that SE provokes an age-specific cytokine expression in the acute phase, and age-
specific glial cell activation in the subacute phase as verified now in the postnatal rat hippocampus. In the juvenile
hippocampus, transient increases in cytokine mRNA expression after SE, in contrast to prolonged glial reactivity and
region-specific microglial activity after SE, suggest that the inflammatory response is changed from a fulminant and
general initial phase to a more moderate and specific subacute response.
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Background
Status epilepticus (SE) has been shown to cause induc-
tion of the innate immunity system in brain, including
hippocampus. In adult rats, several inflammatory media-
tors are activated in response to SE. These include upre-
gulation of cyclooxygenase-2 (COX-2) and cytokines, e.
g. interleukin-1b (IL-1b), tumor necrosis factor-a (TNF-
a), and interleukin-6 (IL-6), together with morphological
and functional changes in glial cells, i.e. microglia and
astrocytes, from resting to active states after either pilo-
carpine- or kainic acid- (KA) induced seizures [1-3].
Furthermore, upon activation by seizures, cytokine (e.g.
IL-1b, TNF-a, and IL-6) expression is increased in both
glial cell types [4]. It has been suggested that these
responses could contribute to excitotoxic neuronal
damage in the hippocampus, a brain region especially
susceptible to injury caused by SE [5-7].
In contrast to adult brain, SE-induced acute activation
of inflammatory processes seems to be age-specifically
regulated in the developing postnatal rat brain, e.g. post-
natal-day 21 (P21) rats exhibit pronounced inflamma-
tory responses (increases in COX-2 and pro-
inflammatory cytokine expression, and glial cell reactiv-
ity) within 24 h after SE in hippocampus whereas this is
not seen in P9 rats [6,8]. Additionally, SE-induced neu-
ronal damage has been shown to differ according to age;
younger brain being more resistant to seizure-induced
damage than older brain [9,10]. In the hippocampus of
juvenile rats, neuronal damage caused by a single epi-
sode of SE is localized in the CA1 or CA3 pyramidal
cell regions [6,8]. Although more thoroughly studied in
the adult rat brain, classical pro-inflammatory cytokines
(IL-1b, TNF-a, and IL-6) have been found to be upregu-
lated within a few hours after SE in juvenile hippocam-
pus as well [6]. However, whether SE leads to
augmented expression of other cytokines involved in
inflammation has remained unaddressed in the develop-
ing hippocampus. Such factors include anti-inflamma-
tory cytokines, matrix metalloproteinases, growth factors
and interferons. The anti-inflammatory cytokine, inter-
leukin-10 (IL-10), can suppress pro-inflammatory cyto-
kine signalling in macrophages and microglia by
inhibiting STAT-1a activation [11], and IL-10 expres-
sion is upregulated after excitotoxic lesions in P9 rat
brain [12]. Matrix metalloproteinases (MMP) are known
to regulate the metabolism of the pericellular environ-
ment and, in particular, MMP-9 activity is increased
after KA-induced SE in the hippocampus of adult rats
[13]. Furthermore, transforming growth factor-b1 (TGF-
b1) has been proposed to protect neurons from rapid
KA-induced excitotoxicity, possibly by inhibiting the rise
in intracellular Ca2+ [14], and on the other hand, to
contribute to remodelling of brain after injury by regu-
lating expression of MMP-9 in astrocytes and inducing
their migration [15]. Glial cell-derived neurotrophic fac-
tor (GDNF) is a potent survival factor for several types
of neurons, and its mRNA expression is increased in
adult rat hippocampus 6-24 h after intraperitoneal (i.p.)
KA injection [16]. In addition, interferon-g (IFN-g) has
been suggested to have a neuroprotective function as
well, since it may induce neurotrophic growth factor
(NGF) production in activated astrocytes obtained from
rat brain that has been lesioned by intracerebral 6-
hydroxydopamine injection [17]. Also, the temporal
behaviour of glial cells after SE is incompletely known
in P9 and P21 rat hippocampus, since there are no in
vivo studies at these ages in which the reactivity of glial
cells has been investigated beyond 24 h after KA-
induced SE.
The current study was designed to obtain more
detailed information of the temporal and developmental
profiles of inflammatory processes activated by SE. For
this purpose, we investigated mRNA expression of the
cytokines IL-1b, TNF-a, IL-10, MMP-9, GDNF, IFN-g,
and TGF-b1 with real-time quantitative PCR (qPCR) in
P9 and P21 rats 4-24 h, and also in P21 rats 3 d after
KA-induced SE. Additionally, IL-1b protein expression
was measured 8 h after SE in P21 rats. Immunohisto-
chemistry was used to investigate microglial and astro-
cyte morphology subacutely (3 days) after SE, and the
observed changes were quantified by counting microglial
cells with active morphology and by GFAP western blot-
ting, respectively.
Methods
Experimental animals in kainic acid-induced status
epilepticus
All animal experiments were conducted in accordance
with the guidelines of the European Community Council
Directives 86/609/EEC, and had the approval of the
Office of the Regional Government of Western Finland.
All efforts were made to minimize the pain, discomfort,
and number of experimental animals.
The procedure of KA-induced SE was carried out as
recently described in detail [18]. Since two age groups
(P9 and P21) of Sprague-Dawley rats were used, the
procedure applied for each group is described separately.
Group 1: P9 rat pups were weighted, and a single dose
of KA (1.2 mg/kg) (Tocris Cookson Ltd., Avomouth,
UK) was given i.p. Within 20-30 min after the injection,
the pups first manifested stiffening, scratching, head
nodding, and forelimb clonus with further progression
to generalized tonic-clonic seizures within 45-60 min,
which continued intermittently for 3-4 h after the KA
injection. The mortality of the rat pups was negligible.
After the cessation of seizures, the pups were taken
back to the cages with their mother, and used for the
qPCR and immunocytochemical studies 4 h, 8 h, 24 h
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and 3 days after the KA injection. Instead of KA injec-
tion, P9 control rats received the comparable volume of
0.9% NaCl as given to the KA-treated rats. The KA-trea-
ted and their age-matched control rats were separated
from their mothers for an equivalent amount of time.
Group 2: P21 rats were weighted, and a single dose of
KA (7 mg/kg) was given (i.p.). Within 20-30 min, rats
first showed scratching, chewing, and myoclonic jerks
followed by wet dog shakes, head nodding, forelimb clo-
nus, and rearing and falling. Behavioural signs of gener-
alized tonic-clonic seizures occurred within 45-60 min,
which continued intermittently for 3-4 h after the KA
injection. The mortality within this age group was negli-
gible as well. Rats were used for the qPCR, immunocy-
tochemical and ELISA studies 4 h, 8 h, 24 h, and 3 days
after the KA injection. Instead of KA injection, P21 con-
trol rats received the comparable volume of 0.9% NaCl
as given to the KA-injected rats, but were otherwise
treated as their age-matched treated rats. Rats were
visually followed-up for about 2 h after the cessation of
behavioural seizure signs, and taken back to their cages.
All KA-injected rats of both age groups included in this
study manifested the behavioural seizure signs as
described above.
Immunocytochemistry
Immunocytochemistry was performed as previously
described in detail for neurofilament proteins with some
modifications [18]. Briefly, rats (n = 3 in both age
groups of treated and control rats) were deeply anesthe-
tized with 50 mg/kg of pentobarbital, and fixed by trans-
cardiac perfusion with 4% paraformaldehyde in
phosphate-buffered saline (PBS, pH 7.4). Brains were
rapidly removed, postfixed at +4°C, processed with the
antigen retrieval protocol [19], cryoprotected in 30%
sucrose in PBS at +4°C, frozen, and kept at -80°C until
used. For immunostaining, brains were cryosectioned in
40 μm slices, collected in Tris buffered-saline (TBS, pH
7.4) containing 0.1% Triton X-100, and immediately
processed in a free-floating system. First, slices were
incubated in a blocking solution (BS) containing 3%
bovine serum albumin (BSA), 0.1% Triton X-100 in TBS
(pH 7.4), and thereafter with the primary antibodies
against Iba1 (1:1000, Wako, Japan) or GFAP (1:1000,
Sigma, St Louis, MO, USA) overnight at +4°C in BS.
After washings, slices were incubated with a biotin SP-
conjugated secondary antibody (1:1000), followed by
incubation with the avidin-peroxidase conjugate (Vectas-
tain ABC Kit, Vector Laboratories, Burlingame, CA).
Staining was detected using 3,3’-diaminobenzidinetetra-
hydrochloride (DAB) (Sigma) as a chromogen. In each
experiment, KA-treated and control brains were pro-
cessed simultaneously to minimize the possible interex-
perimental differences in the staining. Three to four
slices, in which the primary antibody was omitted but
which were otherwise treated as indicated above, served
as negative controls. The immunoreactivity was exam-
ined with a Leica DMR microscope (Heerbrugg, Ger-
many) under bright field; pictures were captured using
an Olympus U-TV1 X digital camera (Olympus Optical,
Tokyo, Japan), and further processed with Adobe Photo-
shop Elements (version 3.0) and Corel Draw (version
11.0).
In a subset of experiments with the primary antibody
against GFAP (1:1000, Sigma), slices were further incu-
bated with a fluorescent secondary antibody Alexa 488
(Invitrogen, Carlsbad, CA, USA), which was diluted
(1:1000) in TBS containing 3% BSA and 0.1% Triton X-
100. After the staining, slides were dehydrated, cover-
slipped, and examined with the Leica DMR microscope
using the appropriate fluorescence filter. The images
were further processed with Corel Draw (version 11.0).
Real-time quantitative PCR
For qPCR, hippocampi (n = 5-6 in each time-point)
were taken from P9 and P21 rats 4 h, 8 h or 24 h after
KA injection, and those from saline-injected control
groups of the two ages. Additionally, a group of P21
rats, in which hippocampi were prepared 3 days after
SE, was used for qPCR, together with their own age-
matched control group. Rats were decapitated, hippo-
campi quickly isolated, immediately frozen in -196°C
liquid nitrogen, and stored at -70°C until used. For the
experiments, frozen hippocampi were thawed, homoge-
nized with Ultra-Turrax, and the total RNA extraction
was carried out with Qiagen RNeasy mini kit (Qiagen,
Hilden, Germany) using the protocol supplied by the
manufacturer. Total RNA was reverse transcribed to
cDNA by M-MuLV Reverse Transcriptase RNase H+
(including RNase inhibitor) (Finnzymes, Espoo, Finland).
PCR was performed using TaqMan One-Step qPCR
Master Mix Reagents Kit (Applied Biosystems, Foster
City, CA, USA). Amplification was carried out with the
ABI 7300 Real-Time PCR System (Applied Biosystems)
with a two-step PCR protocol (preincubation of 10 min
at +95°C followed by 40 cycles at +95°C for 15 sec, and
for 1 min at +60°C). All cytokine primers and probes
were designed using the Primer Express software
(Applied Biosystems) avoiding contaminating genomic
DNA amplification by positioning one of the primers or
a probe over the exon/intron boundary. The cytokine
cDNA was amplified using the primers and probes as
given in Table 1.
mRNA quantification results were normalized using
rat ribosomal 18s RNA (rRNA) (Applied Biosystems) as
an endogenous control. Before the study, the stability of
rRNA expression in the samples was validated with an
experiment in which different concentrations of a
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sample mRNA were used and rRNA expression was
measured. The stability of rRNA also in stress condi-
tions has been previously tested [20]. In all studies, each
sample was run in triplicate, and the comparative
threshold (CT) method (= ΔΔCT method) was used to
examine the relative quantification of the samples (Rela-
tive Quantitation computer software, Applied Biosys-
tems). Fold-expression changes were calculated using
the equation 2-ΔΔCT.
ELISA
For IL-1b ELISA, three control rats and four KA-
injected P21 rats (8 h after injection) were used. Rats
were decapitated and hippocampi quickly isolated,
placed in ice-cold homogenization buffer containing 50
mM Tris-HCl (pH 7.4), 1% sodium dodecyl sulphate
(SDS), 2 mM EDTA, 1 mM phenylmethylsulphonyl-
fluoride (PMSF), and 0.7 mM dithiothreitol, homoge-
nized (Ultra-Turrax T25, Janke and Kunkel, Staufen,
Germany), boiled, and centrifuged at +4°C. The super-
natants were frozen and stored at -80°C until used.
Total protein concentration of the samples was mea-
sured using a Lowry-based assay (Bio-Rad, CA, USA). A
commercial ELISA kit (Raybiotech, Norcross, GA, USA)
was used, and the protocol supplied by the manufac-
turer was followed. Results are calculated as pg of IL-
1b/mg of total protein.
Western blotting
Western blotting studies were performed as previously
described in detail with slight modifications [18]. Briefly,
two separate sets of P21 rats, three to four rats at each
time point in each set, were used for western blotting
studies at 1 and 3 days after KA injection. Different age-
matched controls were used for both time-points. Rats
were decapitated and hippocampi were rapidly removed
and placed in ice-cold homogenization buffer containing
50 mM Tris-HCl, 1% SDS, 2 mM EDTA, 1 mM PMSF,
and 0.7 mM DTT (pH 7.4). Thereafter, hippocampi were
homogenized, boiled, and centrifuged at +4°C. The
supernatants were collected and stored at -70°C until
used. Total protein concentration of the samples was
measured using the Lowry based Biorad DC Protein
assay (Bio-Rad, CA, USA). For SDS-PAGE, equal
amounts of protein were applied to each lane of 7.5%
acrylamide mini gels, separated by electrophoresis, and
transferred to a polyvinylidene fluoride membranes,
which were then incubated overnight at +4°C with the
monoclonal GFAP primary antibody (Sigma) diluted
1:4500. After that, the membranes were washed and
incubated with HRP-conjugated secondary antibody
(1:4000) for 1 h at room temperature. The signal was
obtained using a chemiluminiscence ECL system (Amer-
sham, Buckinghamshire, UK), and exposed to a film
(Hyperfilm ECL, Amersham) that was then developed,
and the optical signals were quantified with Image J 1.20s
(NIH, USA). The control level was set at 100%, and
changes in expression are given as percentage of controls.
Western blotting studies were repeated four times with
the two sets of rats. Actin (1:4500) (Sigma-Aldrich Inc)
was used as a loading control for western blotting.
Statistical analysis
Statistical significance of differences between groups was
analyzed with one-way ANOVA with Tukey’s test as a
post test for experiments in which there were three or
more groups. Differences between the two age groups at
the studied time-points were analyzed with two-way
ANOVA. Statistical significance of differences in experi-
ments having two groups was analyzed with Student’s
unpaired t-test. All statistical analyses were performed
using the GraphPad Prism software program (version
4.0, GraphPad Software, San Diego, CA, USA). The level
of significance was set at p < 0.05.
Results
Age-dependent changes in cytokine mRNA expression
mRNA expression of IL-1b, TNF-a, IL-10, MMP-9,
GDNF, IFN-g, and TGF-b1 was investigated 4, 8 and 24
h following KA injection in P9 and P21 rat hippocampi.
Additionally, mRNA expression of these cytokines was
also studied 3 d after KA injection in P21 rats.
IL-1b mRNA expression in P21 rat hippocampi
already showed a pronounced increase 4 h after KA
Table 1 The sequences of primers and probes used to amplify cytokine cDNA
Cytokine 5’ primer 3’ primer Probe
GDNF GCCACCATCAAAAGACTGAAAAG CGGTTCCTCTCTCTTCGAGGA TCACCAGATAAACAAGCGGCGGCA
IFN-g TCGAATCGCACCTGATCACTA GGGTTGTTCACCTCGAACTTG CATCCTTTTTTGCTTTACTGTTGCTGAGAAG
IL-1b GAAAGACGGCACACCCACC AAACCGCTTTTCCATCTTCTTCT TGCAGCTGGAGAGTGTGGATCCCAAAC
IL-10 CCCTCTGGATACAGCTGCG GCTCCACTGCCTTGCTTTTATT CGCTGTCATCGATTTCTCCCCTGTGA
MMP-9 GTATGGTCGTGGCTCTAAACCTG TCGGCTGTGGTTCAGCTG CCCAAGGCCTCCAGCCACCAC
TGF-b1 TGAGTGGCTGTCTTTTGACGTC CCTGTATTCCGTCTCCTTGGTT CTGGAGTTGTCCGGCAGTGGCTGA
TNF-a GACCCTCACACTCAGATCATCTTCT ACGCTGGCTCAGCCACTC TAGCCCACGTCGTAGCAAACCACCAA
The probes were labeled with FAM at the 5’ end and with TAMRA at the 3’ end.
Järvelä et al. Journal of Neuroinflammation 2011, 8:29
http://www.jneuroinflammation.com/content/8/1/29
Page 4 of 12
Figure 1 Cytokine mRNA expression patterns in immature and juvenile hippocampus after KA-induced SE. Relative quantification of IL-
1b (A), TNF-a (B), IL-10 (C), MMP-9 (D), GDNF (E), IFN-g (F), and TGF-b1 (G) mRNA expression 4, 8 and 24 h after KA-injection in P9 and P21 rat
hippocampi, and 3 d after KA-injection in P21 rat hippocampi (H) measured with real-time PCR. Note the significant increases from control levels
in both age groups, more pronounced and faster induction of IL-1b, TNF-a and IL-10 mRNA expression in P21 compared to P9 rats, and the
increase in GDNF expression only in P21 rats. Note also the return of cytokine mRNA expression in P21 rats to control levels 3 d after KA
injection. Data are given as mean ± S.E.M. *p < 0.05, compared to age-matched control (one-way ANOVA); **p < 0.01, compared to age-
matched control (one-way ANOVA). ***p < 0.001, compared to age-matched control (one-way ANOVA); ##p < 0.01, compared to the other age
at the same time-point (two-way ANOVA); ###p < 0.001, compared to the other age at the same time-point (two-way ANOVA). Abbreviations: C,
control; P, postnatal.
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injection, peaked at 8 h, when it was almost 25-fold
higher compared to that of controls, and still remained
significantly higher than in the control group at 24 h
(Figure 1A). In contrast, in P9 rats, IL-1b mRNA
expression did not significantly change from the control
group 4 h or 8 h after KA injection, while at 24 h its
expression was slightly but significantly augmented. To
confirm the increased expression after SE at the protein
level, IL-1b protein expression in the hippocampus of
P21 rats was studied with ELISA 8 h after KA injection.
The concentration of IL-1b protein was 95.3 ± 7.8 pg/
mg (mean ± SEM, n = 3) in the control group, and was
significantly (p < 0.05, unpaired t-test) increased to
124.3 ± 10.1 pg/mg (mean ± SEM, n = 4) in the KA-
treated group (8 h after injection).
TNF-a mRNA expression closely followed the tem-
poral expression profile of IL-1b (Figure 1B). In P21 rat
hippocampi, TNF-a mRNA expression already showed a
pronounced increase 4 h after KA injection, at which
time it peaked, and thereafter decreased to control
levels, its expression not being significantly different
from that of control rats at 24 h. In P9 rats, TNF-a
mRNA expression was significantly increased over the
first 8 h after KA injection, and remained elevated up to
24 h. It is of importance to note that the augmented
expression of this cytokine 8 h after KA injection was
significantly more pronounced in P21 rats (10-fold) than
in P9 rats (3 to 4-fold).
IL-10 mRNA had a somewhat different expression
pattern compared to those of IL-1b and TNF-a (Figure
1C). In P21 rats, its expression was significantly
increased at 4 h but thereafter it sharply decreased, and
at 8 h its expression did not differ from that of the con-
trol level. In P9 rats, however, the increase in IL-10
mRNA expression was more gradual, first reaching sig-
nificance 8 h after SE, and thereafter returning to con-
trol levels by 24 h.
The two age groups had more similarities in the
MMP-9 mRNA expression patterns (Figure 1D). In both
age groups, this expression was significantly increased 8
h after KA. However, in P21 rats the expression
decreased to levels comparable to that of their age-
matched control group at 24 h, whereas in P9 rats it
remained significantly augmented. In P21 rats, GDNF
expression was significantly increased at 4 h after KA
injection, and remained elevated at 8 h and 24 h (Figure
1E), whereas in P9 rat hippocampi its expression
remained unaltered after SE at all time-points studied.
In both age groups, the expression of neither IFN-g
(Figure 1F) nor TGF-b1 (Figure 1G) was significantly
augmented compared to their respective age-matched
controls at any time-point studied.
To study whether the SE-induced increase in expres-
sions of the studied cytokines was prolonged beyond the
acute phase, their mRNA expression was also measured
3 d after SE in P21 rats and in their age-matched con-
trol group. However, the expression levels of all cyto-
kines studied did not significantly differ from those of
controls 3 d after SE (Figure 1H).
Age-dependent glial cell reactivity after SE
In order to investigate subacute glial cell reactivity after
SE in hippocampus, the morphology of microglia and
astrocytes was studied with immunohistochemistry 3 d
after SE in both age groups. There were no discernible
differences in Iba immunostaining in hippocampus
between control and KA-treated P9 rats, as microglia
retained their resting appearance after KA treatment in
both groups (Figurs 2A-D). In contrast, in KA-treated
P21 rats, the morphology of microglial cells changed
from the resting appereance of the control hippocampi
to an active appearance. Activated microglial cells were
characterized by enlarged cell bodies and thicker pro-
cesses in increased numbers (Figurs 2E-H). Microglial
activation was detected to some extent throughout the
hippocampus, but it is of importance to note that Iba1
immunoreactivity and morphological changes were most
prominent in the microglia within the CA1 region. To
quantify this, microglia with active appearance in the
CA1 region were counted, in a blinded manner, in P21
rats from areas as indicated by the boxes in Figurs 2E
and 2G. The number of microglia with an active appear-
ance was 4.5 ± 0.6 (mean ± SEM, n = 4) in the control
group and 14.8 ± 0.9 (mean ± SEM, n = 4) in the KA-
treated group. This increase was statistically significant
(p < 0.0001, Student’s unpaired t-test). Also in the
amygdala of P21 rats, similar microglial activation was
observed 3 d after SE (Figurs 2I-J). In P9 rats, no mor-
phological changes indicating microglial activation were
observed in the amygdala (data not shown).
GFAP immunostaining of P9 rat hippocampi did not
reveal any changes between controls and KA-treated
rats 3 d after SE, including the CA1 region (Figurs 3A-
B). In contrast, in KA-treated P21 rats, GFAP immunos-
taining revealed enlarged cell bodies and thickened pro-
cesses in astrocytes denoting activated morphology
throughout the hippocampus, including the CA1 region,
whereas in the control P21 rats astroglial cells in the
hippocampus had thin processes and a small cell bodies
(Figurs 3C-D). The apparent increase in GFAP expres-
sion in P21 rats was confirmed with western blotting,
and GFAP protein expression was found to be signifi-
cantly increased 3 d after SE, but not yet 1 d after SE
(Figurs 3E-F).
Discussion
The main findings of our study, in which immature and
juvenile rats had KA-induced SE, were the following:
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Figure 2 Microglial morphology in immature and juvenile hippocampus 3 d after SE. Representative Iba1 immunostaining images of
hippocampus for a P9 (A-B) and a P21 (E-F) control rat, and a KA-treated P9 (C-D) and P21 (G-H) rat 3 d after SE, and those of the basomedial
amygdala of a control (I) and a KA-treated (J) P21 rat 3 d after SE. The box in the CA1 region in A, C, E, and G is shown with a higher
magnification in B, D, F and H, respectively. Note the morphological changes in microglia in the CA1 region (arrow, G) with more pronounced
Iba1 immunoreactivity and thickened processes in the KA-treated P21 rat, and the lack of change in P9 rats. Note also the morphological
changes of the microglia in amygdala of the P21 rat. Abbreviations: C, control; KA, KA-treated; P, postnatal. Scale bars: 1 mm in A, applicable also
for C, E and G; 50 μm in B, applicable also for D, F, H, I and J.
Järvelä et al. Journal of Neuroinflammation 2011, 8:29
http://www.jneuroinflammation.com/content/8/1/29
Page 7 of 12
First, the expression of a number of cytokine mRNAs
was induced in both juvenile (P21) and immature (P9)
rats after SE; second, the time course and levels of
increase in cytokine mRNA expression after SE varied
according to the age of rats; third, glial cells exhibited
an active appearance in P21 juvenile rats subacutely (3
d) after SE, especially microglia within the CA1 region,
while in P9 immature rats glial cells retained their rest-
ing appearance. These topics are discussed more thor-
oughly below.
Figure 3 Astrocyte morphology in immature and juvenile hippocampus 3 d after SE. Representative images of GFAP immunostainings in
the CA1 region of hippocampus for a P9 (A) and a P21 (C) control rat, and a KA-treated P9 (B) and P21 (D) rat 3 d after SE. The box in C and D
shows a GFAP-positive cell at higher magnification. Note the prominent morphological changes in astrocytes with thickened, heavily GFAP-
positive processes in the KA-treated P21 rat, and the lack of any changes in the P9 rats. A representative western blot (E) and its semi-
quantitative analysis (F) of GFAP expression in P21 rat hippocampus in age-matched controls and 1 and 3 d after KA-induced SE. *p < 0.05,
compared to the age-matched control group (one-way ANOVA). Abbreviations: C, control; KA, KA-treated; P, postnatal. Scale bars: 50 μm in A,
applicable also for B; 50 μm in C, applicable also for D.
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Expression of cytokines after SE
It has previously been shown in developing hippocam-
pus that IL-1b mRNA expression is augmented in P15
and P21 rats but not in P9 rats 4 h after KA-induced
SE, while TNF-a and IL-6 mRNA expression are
increased only in P21 rats [6]. Our recent results are in
accordance with these findings and further show that
the induction of IL-1b and TNF-a mRNA expression is
more prolonged (8 and/or 24 h after SE) in P21 rats
and, although to a lesser extent, also occurs in P9 rats.
Furthermore, in a previous study in which excitotoxic
lesions were induced via NMDA injection in the right
sensorimotor cortex of P9 rats, IL-1b and TNF-a pro-
tein expression was induced in sensorimotor cortex, cor-
pus callosum, and internal capsule 4 h - 24 h after
injection [21]. However, to our knowledge, until now
there has been no evidence of any SE-induced cytokine
gene expression in P9 rats. Our current results suggest
that IL-1b and TNF-a mRNA expression is increased
more rapidly and is more pronounced after SE in the
more mature juvenile hippocampus compared to a
delayed and weak induction in the immature hippocam-
pus. Thus, the time-course and intensity of augmented
IL-1b and TNF-a mRNA expression after SE in P21 rat
hippocampus resembles that of adult rats [2], which
implies that this response is already mature in juvenile
rats. It is noteworthy that, compared to controls, the
increases in IL-1b protein expression 8 h after KA injec-
tion in P21 rats are much lower than the increases in
IL-1b mRNA expression at the same time-point. How-
ever, the selected time-point probably does not repre-
sent the peak in IL-1b protein expression after KA,
which is likely to occur later. Furthermore, the result
does confirm the tendency of increased mRNA expres-
sion to be translated into an increase at the protein
level, albeit not on a one-to-one basis. As the mRNA
expression levels of many other cytokines were also
highly upregulated, it is reasonable to suggest that these
are followed by increases in their corresponding protein
expressions, although these increases might be signifi-
cantly lower and occur at later time-points than the
mRNA changes.
In addition to neurodegeneration, the classical pro-
inflammatory cytokines have been suggested to contri-
bute to epileptogenesis [4]. For example, transgenic
mice overexpressing IL-6 showed increased sensitivity to
seizures [22], and chronic IL-1b expression has recently
been associated with the development of spontaneous
limbic seizures after prolonged febrile seizures in P11
rats [23]. Conversely, the IL-1 receptor antagonist (IL-
1Ra) mediates anticonvulsant effects in adult rodents in
a number of limbic seizure models (i.e. intrahippcompal
KA and bicuculline injection, and electrical kindling)
[24]. The initial pronounced upregulation of pro-
inflammatory cytokine mRNAs seen in juvenile rats in
our current study might therefore be an early factor
promoting epileptogenesis. While these cytokines can be
produced by both glial cell types after seizures, there
could be some subtle differences between the glial cell
types as to which cytokines they produce, at least in cer-
tain seizure models. For example, 12 h after soman-
induced seizures in adult rats, IL-1b was observed to be
expressed by activated microglia, whereas IL-6 was
expressed by astrocytes in the hippocampus, piriform
cortex and thalamus [25].
mRNA expression of the anti-inflammatory cytokine
IL-10, which has so far been less studied in both imma-
ture and mature brain after SE, was augmented in both
age groups. In an earlier study in P9 rats, in which excito-
toxic brain injury was caused by an intracerebral NMDA
injection, IL-10 and its receptor were upregulated in glial
cells, suggesting a protective role for IL-10 in excitotoxi-
city [12]. In our current study, IL-10 expression was
increased in concert with the pro-inflammatory cytokines
IL-1b and TNF-a, which is in line with the earlier obser-
vation that IL-10 expression may be induced simulta-
neously with pro-inflammatory cytokines in the brain
following an insult [26]. Although the pathways of cyto-
kine expression regulation are intricate, the finding that
induction of IL-10 mRNA expression was quite moderate
and short-lived compared to the more pronounced and
prolonged induction of IL-1b and TNF-a mRNA in P21
rats favours the idea that pro-inflammatory cytokine
expression might overcome IL-10 expression after SE at
this age. In contrast, in P9 rats, IL-10 mRNA expression
showed a more pronounced induction than that of IL-1b
or TNF-a, which suggests that, at this age, IL-10 might
inhibit activated microglial cells and thus suppress
expression of pro-inflammatory cytokines after SE more
effectively than in P21 animals. Furthermore, microglial
cells expressing IL-10 have been shown to attenuate neu-
rodegeneration in hippocampal cultures when apopotosis
is promoted with NMDA [27]. This enables the hypoth-
esis that microglia might self-limit their response via
negative feedback by producing IL-10 and thus can have
either pro-inflammatory or anti-inflammatory functions,
depending on circumstances.
Also MMP-9 mRNA expression increased in both age
groups after SE. In in vitro conditions, MMP-9 has been
shown to be produced by activated microglia [28], and
cytokines are proposed to regulate MMP-9 activity in
astrocytes [29]. In an earlier study, increased MMP-9
activity was observed 8 h after KA-induced seizures in
adult rats, and this was linked with neuronal death as
confirmed in KA-treated organotypic hippocampal slice
cultures (prepared from P11 rats and cultured for 14
days) [30]. In our current study, MMP-9 mRNA expres-
sion increased in both P21 and P9 rats and, as previous
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studies have shown that P9 rats do not exhibit any
detectable neuronal damage from KA-induced SE [6,8],
this suggests that MMP-9 mRNA upregulation after SE
alone is not sufficient to induce neuronal damage in the
P21 rat hippocampus. MMP-9 might have a more cen-
tral role in epileptogenesis, as MMP-9 knockout mice
show lower sensitivity to epileptogenesis after pentylene-
tetrazole kindling-induced seizures, while the sensitivity
of transgenic rats overexpressing MMP-9 is higher [31].
GDNF mRNA expression is augmented in the adult
rat hippocampus 6-24 h after KA-induced SE [16]. In
our study in developing rats, GDNF was the only stu-
died cytokine whose mRNA was increased exclusively in
P21 rats after SE. In another earlier study, in which SE
was induced with KA in adult rats, adenoviral-vector-
delivered GDNF, introduced before KA injection,
increased Bcl-2 expression and reduced the number of
apoptotic cells in the CA3 and dentate gyrus (DG)
regions of the hippocampus compared to the rats, which
did not receive GDNF [32]. This suggests that GDNF
has a neuroprotective role in KA-induced SE. Further-
more, GDNF is proposed to suppress seizures in tem-
poral lope epilepsy models (e.g. kindling) in adult rats
[33]. Our results indicate that GDNF upregulation after
SE is a mechanism that has reached an adult level of
maturity in P21 rats.
The expression of IFN-g and TGF-b1 mRNA did not
significantly change after SE in either age group. In a
recent study in adult rats, IFN-g mRNA expression was
increased in astrocytes of the hippocampus 24 h after
lithium-pilocarpine-induced SE while the expression of
its receptor was upregulated in neurons and, further-
more, neutralization of the IFN-g receptor aggravated
injury suggesting a protective role for IFN-g [34]. Also,
the expression of TGF-b1 mRNA has been shown to be
increased in response to KA-induced SE in microglial
cells in the hippocampus of adult rats [35]. However,
TGF-b1 has recently been suggested to contribute to
epileptogenesis induced by albumin after blood-brain
barrier breakdown in adult rats [36]. Our current find-
ings suggest that these mechanisms, which are activated
by SE in the adult hippocampus, are still underdeve-
loped in the juvenile P21 rat hippocampus.
Our present results together with earlier findings of
other groups suggest that the more mature innate
immunity system elicits a fulminant inflammatory
response after SE, in which the pro-inflammatory reac-
tion is marked. In contrast, the immature system evokes
only a mild pro-inflammatory response, but a marked
anti-inflammatory reaction. We propose that in the
immature brain either the ability to induce acute inflam-
matory reaction is underdeveloped or its emphasis is on
anti-inflammatory properties. Moreover, the inflamma-
tory reaction in developing hippocampus is likely to at
least partly contribute to age-dependent susceptibility to
SE-induced neuronal injury and recurrence of seizures.
However, other factors, such as molecular and func-
tional differences in receptors and ion channels between
the immature and adult rodent brain, may be of equal
or even greater importance in determining changes in
the seizure threshold [37].
Glial cell activation after SE at the acute and the subacute
phase
Glial cells, i.e. microglia and astrocytes, are age-depen-
dently activated (in P21 and P15, but not in P9) in the
postnatal rat hippocampus up to 24 h after KA-induced
SE [6]. Additionally, short-term microglial (a few days)
and long-term (beyond 40 days) astrocytic activation
have been observed after KA-induced seizures in P15
rats, and this has been proposed to contribute to neuro-
nal injury, neurobehavioral impairment, and increased
susceptibility to seizures [38]. Our results further
address this and show that also subacutely, 3 days after
seizures, both types of glial cells remain activated in P21
rats and that glial cells remain inactivated in P9 rats
also at this subacute phase. Furthermore, astrocyte activ-
ity seems to increase over time after SE in P21 rats,
since GFAP expression was now significantly increased
3 d after SE, but not yet 1 d after SE. This further sup-
ports the notion that the more mature brain elicits a
more prominent inflammatory response after SE, which
may be in part due to a diminished ability of glial cells
to self-limit their response. Additionally, it is of impor-
tance to note that the most pronounced subacute
microglial activation was localized to the CA1 pyramidal
cell layer in P21 rats after KA treatment, which is the
region damaged by KA-induced SE in rats of this age
[8]. In contrast, an earlier study has shown that micro-
glia are equally activated in all hippocampal regions 4 h
and 24 h after onset of SE in P21 rats [6]. Our results
therefore suggest that the generalized microglial
response in hippocampus seems to be gradually and
specifically concentrated on the damaged CA1 region at
the subacute phase in P21 rats, whereas the astrocytic
response remains ubiquitous in the hippocampus.
Furthermore, our recent transcriptomic study indicated
pronounced upregulation of the GFAP gene in the CA1
region together with neuronal damage in P21 rats 7
days after SE [39], which denotes long-term astrocyte
activation specifically in the damaged area.
In contrast to prolonged glial cell reaction, increased
expression of cytokine mRNAs is transient and, as our
results show, at three days after SE in P21 rat hippo-
campi, cytokine mRNA expression has returned to con-
trol levels. This suggests that activated glial cells in
juvenile hippocampus may have functions other than
cytokine production during the subacute phase. Indeed,
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microglial response has been shown to be diverse after
their activation, and can include both neurodegenerative
and neuroprotective functions [40]. The induction of
COX-2 expression in adult and P21 rat brain has been
shown to be transient as well, since its expression
returns to the control level within three days after SE
[6,41]. This further suggests that after the initial acute
phase (which seems to last up to 24 h - 3 d), there is a
change in the inflammatory response provoked by KA-
induced SE in juvenile hippocampus, with attenuation of
the pronounced, and perhaps exaggerated, expression of
inflammatory mediators and modulation of microglial
reactivity from widespread activation to a targeted
response in the damaged area.
In our study, microglial activation was now detected
in P21 rats 3 d after SE also in the basomedial amyg-
dala, which together with the hippocampus is a part of
the limbic system and suffers neuronal damage after
KA-induced SE [6]. Furthermore, the expression of
COX-2 and c-Fos has been shown to be markedly
increased in P21 rats after SE in amygdala, this again in
tandem with hippocampus [8,42]. Thus, after the acute
phase post-SE, the inflammatory response at the suba-
cute phase seems to be more accurately targeted to
damaged areas of limbic structures in juvenile rat brain.
Conclusions
In conclusion, SE transiently induced mRNA expression
of a number of cytokines in both immature and more
mature juvenile rat hippocampus. In general, the
increases in cytokine mRNA expressions were more
pronounced and rapid in juvenile brain than in imma-
ture brain. Glial cells still exhibited an active appearance
subacutely after SE in juvenile hippocampus while
retaining their resting appearance in immature hippo-
campus. In juvenile hippocampus, the transient augmen-
tation of cytokine mRNA expression after SE, in
contrast to the persistence of glial cell reaction including
region-specific microglial activity at the subacute phase,
suggests a regulated shift from a fulminant and general
initial reaction towards a more moderate and precisely
targeted response.
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